Sun Y, Zhou T, Ye S, Lau E, Zeng Y, Liang J
PLoS One. 2025; 20(2):e0317038.
PMID: 39903728
PMC: 11793731.
DOI: 10.1371/journal.pone.0317038.
Arteaga-Blanco L, Evans A, Dixon D
Cells. 2024; 13(14).
PMID: 39056778
PMC: 11274984.
DOI: 10.3390/cells13141195.
Bonnet V, Maikranz E, Madec M, Vertti-Quintero N, Cuche C, Mastrogiovanni M
Proc Natl Acad Sci U S A. 2024; 121(11):e2316500121.
PMID: 38442157
PMC: 10945811.
DOI: 10.1073/pnas.2316500121.
Park R, Lee S, Chin H, Nguyen A, Lee D
Cancers (Basel). 2023; 15(18).
PMID: 37760541
PMC: 10527020.
DOI: 10.3390/cancers15184572.
Yanagihara H, Morioka T, Yamazaki S, Yamada Y, Tachibana H, Daino K
J Radiat Res. 2023; 64(3):622-631.
PMID: 37117033
PMC: 10215001.
DOI: 10.1093/jrr/rrad021.
Morphology dynamics in intestinal crypt during postnatal development affect age-dependent susceptibility to radiation-induced intestinal tumorigenesis in ApcMin/+ mice: possible mechanisms of radiation tumorigenesis.
Sasatani M, Shimura T, Doi K, Zaharieva E, Li J, Iizuka D
Carcinogenesis. 2022; 44(1):105-118.
PMID: 36546734
PMC: 10183640.
DOI: 10.1093/carcin/bgac100.
Shifting the Focus of Signaling Abnormalities in Colon Cancer.
Brown M, Ried T
Cancers (Basel). 2022; 14(3).
PMID: 35159051
PMC: 8834070.
DOI: 10.3390/cancers14030784.
Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids.
Babaei-Jadidi R, Kashfi H, Alelwani W, Karimi Bakhtiari A, Kattan S, Mansouri O
Oncogenesis. 2022; 11(1):4.
PMID: 35046388
PMC: 8770633.
DOI: 10.1038/s41389-021-00376-1.
High Variability in Cellular Proliferation, Gene Expression, and Cytokine Production in the Nonneoplastic Colonic Epithelium of Young Mice.
Leystra A, Harvey K, Kaunga E, Hensley H, Vanderveer L, Devarajan K
Front Oncol. 2021; 11:705562.
PMID: 34513688
PMC: 8429936.
DOI: 10.3389/fonc.2021.705562.
Moderate DNA hypomethylation suppresses intestinal tumorigenesis by promoting caspase-3 expression and apoptosis.
Duan X, Huang Y, Chen X, Wang W, Chen J, Li J
Oncogenesis. 2021; 10(5):38.
PMID: 33947834
PMC: 8096944.
DOI: 10.1038/s41389-021-00328-9.
Animal Models of Colorectal Cancer: From Spontaneous to Genetically Engineered Models and Their Applications.
Nascimento-Goncalves E, Mendes B, Silva-Reis R, Faustino-Rocha A, Gama A, Oliveira P
Vet Sci. 2021; 8(4).
PMID: 33916402
PMC: 8067250.
DOI: 10.3390/vetsci8040059.
Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer.
Wang Y, Bhave M, Yagita H, Cardell S
Front Immunol. 2020; 11:581301.
PMID: 33193386
PMC: 7606378.
DOI: 10.3389/fimmu.2020.581301.
The GM-CSF-IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses.
Arnold I, Artola-Boran M, Gurtner A, Bertram K, Bauer M, Frangez Z
J Exp Med. 2020; 217(12).
PMID: 32970801
PMC: 7953737.
DOI: 10.1084/jem.20190706.
Degree and site of chromosomal instability define its oncogenic potential.
Hoevenaar W, Janssen A, Quirindongo A, Ma H, Klaasen S, Teixeira A
Nat Commun. 2020; 11(1):1501.
PMID: 32198375
PMC: 7083897.
DOI: 10.1038/s41467-020-15279-9.
Epigenetic loss of heterozygosity of Apc and an inflammation-associated mutational signature detected in Lrig1-driven murine colonic adenomas.
Preston J, Stiffler N
BMC Cancer. 2020; 20(1):126.
PMID: 32059662
PMC: 7023705.
DOI: 10.1186/s12885-020-6616-y.
IL-17 inhibits CXCL9/10-mediated recruitment of CD8 cytotoxic T cells and regulatory T cells to colorectal tumors.
Chen J, Ye X, Pitmon E, Lu M, Wan J, Jellison E
J Immunother Cancer. 2019; 7(1):324.
PMID: 31775909
PMC: 6880503.
DOI: 10.1186/s40425-019-0757-z.
Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review.
Rosa-Caldwell M, Fix D, Washington T, Greene N
J Appl Physiol (1985). 2019; 128(1):25-41.
PMID: 31725360
PMC: 6985812.
DOI: 10.1152/japplphysiol.00622.2019.
UCP2 Deficiency Increases Colon Tumorigenesis by Promoting Lipid Synthesis and Depleting NADPH for Antioxidant Defenses.
Aguilar E, Esteves P, Sancerni T, Lenoir V, Aparicio T, Bouillaud F
Cell Rep. 2019; 28(9):2306-2316.e5.
PMID: 31461648
PMC: 6718829.
DOI: 10.1016/j.celrep.2019.07.097.
RIPK3-Induced Inflammation by I-MDSCs Promotes Intestinal Tumors.
Jayakumar A, Bothwell A
Cancer Res. 2019; 79(7):1587-1599.
PMID: 30786994
PMC: 7395226.
DOI: 10.1158/0008-5472.CAN-18-2153.
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
Mieszczanek J, van Tienen L, Ibrahim A, Winton D, Bienz M
Nat Commun. 2019; 10(1):724.
PMID: 30760710
PMC: 6374407.
DOI: 10.1038/s41467-018-08164-z.